Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) FCF Margin: 2009-2024

Historic FCF Margin for Ironwood Pharmaceuticals (IRWD) over the last 16 years, with Dec 2024 value amounting to 29.43%.

  • Ironwood Pharmaceuticals' FCF Margin rose 2821.00% to 38.98% in Q3 2025 from the same period last year, while for Sep 2025 it was 19.96%, marking a year-over-year decrease of 1276.00%. This contributed to the annual value of 29.43% for FY2024, which is 1194.00% down from last year.
  • Latest data reveals that Ironwood Pharmaceuticals reported FCF Margin of 29.43% as of FY2024, which was down 28.87% from 41.37% recorded in FY2023.
  • In the past 5 years, Ironwood Pharmaceuticals' FCF Margin registered a high of 66.64% during FY2022, and its lowest value of 29.43% during FY2024.
  • In the last 3 years, Ironwood Pharmaceuticals' FCF Margin had a median value of 41.37% in 2023 and averaged 45.81%.
  • In the last 5 years, Ironwood Pharmaceuticals' FCF Margin skyrocketed by 4,205bps in 2020 and then crashed by 2,527bps in 2023.
  • Yearly analysis of 5 years shows Ironwood Pharmaceuticals' FCF Margin stood at 42.87% in 2020, then surged by 2,036bps to 63.23% in 2021, then soared by 341bps to 66.64% in 2022, then tumbled by 2,527bps to 41.37% in 2023, then tumbled by 1,194bps to 29.43% in 2024.